A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2017
At a glance
- Drugs PGG-glucan (Primary) ; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 22 Jun 2015 According to a Biothera media release, dosing in this trial has begun.
- 14 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 14 Apr 2014 New trial record